daunorubicin has been researched along with Endometrial Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abal, M; Alonso-Alconada, L; Brea, J; Colás, E; Cuadrado, E; Ferreño, N; Gil-Moreno, A; Herrero, C; López-López, R; Loza, MI; Moiola, CP; Pérez-Díaz, A | 1 |
1 other study(ies) available for daunorubicin and Endometrial Neoplasms
| Article | Year |
|---|---|
Modeling ANXA2-overexpressing circulating tumor cells homing and high throughput screening for metastasis impairment in endometrial carcinomas.
Topics: Animals; Annexin A2; Cell Adhesion; Cell Line; Cell Movement; Cell Proliferation; Daunorubicin; Endometrial Neoplasms; Endothelium; Female; High-Throughput Screening Assays; Humans; Liquid Biopsy; Mice; Models, Biological; Neoplastic Cells, Circulating | 2021 |